RespiQ joins Dutch research consortium P4O2

The quality of life for patients with chronic lung diseases like asthma, COPD, and lung cancer can- and should be improved. The Dutch consortium “Precision Medicine for more Oxygen” (P4O2) will start a research program to fundamentally improve the early detection, prevention, and treatment of lung disease. Coordinated by Amsterdam UMC, the P4O2 consortium has a budget of over 14.5 million Euros and is co-funded by Top Sector Life Sciences & Health (Health~Holland). The part of the research we participate in will focus on lifestyle intervention and personalized nutrition.

We are very proud to be partner in this research.